Commerce Bank’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,296
Closed -$300K 1233
2024
Q3
$300K Buy
13,296
+1,946
+17% +$40.2K ﹤0.01% 1059
2024
Q2
$221K Sell
11,350
-38
-0.3% -$995 ﹤0.01% 1112
2024
Q1
$427K Buy
11,388
+30
+0.3% +$1.32K ﹤0.01% 911
2023
Q4
$636K Hold
11,358
﹤0.01% 760
2023
Q3
$469K Sell
11,358
-622
-5% -$32.4K ﹤0.01% 818
2023
Q2
$669K Sell
11,980
-58
-0.5% -$3.14K 0.01% 702
2023
Q1
$672K Buy
12,038
+826
+7% +$38.6K 0.01% 698
2022
Q4
$409K Buy
11,212
+143
+1% +$4.67K ﹤0.01% 869
2022
Q3
$315K Buy
11,069
+5,445
+97% +$207K ﹤0.01% 929
2022
Q2
$254K Buy
+5,624
New +$292K ﹤0.01% 1019
2022
Q1
Sell
-3,225
Closed -$480K 1223
2021
Q4
$480K Buy
3,225
+99
+3% +$15.2K ﹤0.01% 866
2021
Q3
$455K Buy
3,126
+1,384
+79% +$238K ﹤0.01% 868
2021
Q2
$341K Buy
1,742
+80
+5% +$14.5K ﹤0.01% 960
2021
Q1
$301K Buy
+1,662
New +$287K ﹤0.01% 972

Other funds holding TXG

Commerce Bank's TXG Position: Q4 2024 in Review

Commerce Bank sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 13,296 shares — an estimated $300K sold.

Commerce Bank first reported a position in TXG in Q1 2021 and held it in 14 quarters. The position peaked at $672K in Q1 2023. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Commerce Bank reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Commerce Bank sold 13,296 10x Genomics shares in Q4 2024, an estimated $300K.
  • Commerce Bank first reported a position in 10x Genomics in Q1 2021 and held it in 14 quarters.
  • Commerce Bank's 10x Genomics position peaked at $672K in Q1 2023.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Commerce Bank's 13F filing for Q4 2024, filed 13 Feb 2025.